Literature DB >> 7614988

A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG.

S K Reitan1, K Hannestad.   

Abstract

Some syngeneic monoclonal antibodies (mAb) elicit immune responses like conventional T-dependent antigens. To find out whether the heavy chain class (isotype) plays a role for the immunogenicity of an idiotype (Id), we isolated rare subclones of an IgM mAb (termed Id3) in which the variable region of the heavy chain (VH) is associated with a new constant region (CH). The VH-Id3 gene is a member of the murine 36-60 family and probably has three replacement mutations. The light chain V gene is germ-line V lambda 2. IgM, IgG1, IgG2a and IgG2b variants of Id3 were purified from protein-free medium and injected without adjuvant into BALB/c mice. The parental 19S IgM mAb given subcutaneously (s.c.) elicited a vigorous humoral response against Id3; in comparison, monomeric 8S IgM was a much weaker immunogen. Unlike IgM, multiple challenges with the IgG switch variants failed to induce anti-Id3 Ab. IgG variants gained immunogenicity if they were purified from medium containing fetal calf serum, mixed with complete Freund's adjuvant or injected into mice primed with IgM-Id3. Pretreatment with 100 micrograms s.c. + 50 micrograms of the IgG2a variant extinguished the Ab response to parental IgM, but the response to adjuvant-free bovine serum albumin was intact. Therefore, the tolerance induced by the IgG2a switch variant is antigen-specific and not due to toxicity. Significant inhibition of the Ab response to parental IgM was observed after treatment with 4 micrograms of the IgG2a switch variant. Administration of the IgG1 and IgG2b switch variants also inhibited this response significantly. Thus, the outcome of an encounter with Id3 is strongly influenced by the CH isotype to which the Id is joined. This suggests novel ways to minimize unwanted Ab responses against Id of human therapeutic mAb. In the context of the theory of Id networks, we suggest that dominant B cell clones can preempt anti-Id Ab responses against themselves by early switching from IgM to IgG secretion, before immunogenic IgM Ab have had time to activate anti-Id B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614988     DOI: 10.1002/eji.1830250620

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.

Authors:  Solveig Klaebo Reitan; Kristian Hannestad
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.

Authors:  Stephen J Schuster; Sattva S Neelapu; Barry L Gause; John E Janik; Franco M Muggia; Jon P Gockerman; Jane N Winter; Christopher R Flowers; Daniel A Nikcevich; Eduardo M Sotomayor; Dean S McGaughey; Elaine S Jaffe; Elise A Chong; Craig W Reynolds; Donald A Berry; Carlos F Santos; Mihaela A Popa; Amy M McCord; Larry W Kwak
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

3.  Variable region identical immunoglobulins differing in isotype express different paratopes.

Authors:  Alena Janda; Ertan Eryilmaz; Antonio Nakouzi; David Cowburn; Arturo Casadevall
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

4.  Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences.

Authors:  Alena Janda; Ertan Eryilmaz; Antonio Nakouzi; Mary Ann Pohl; Anthony Bowen; Arturo Casadevall
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

Review 5.  Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

Authors:  Elena Muraro; Debora Martorelli; Riccardo Dolcetti
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

6.  Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.

Authors:  Alejandro López-Requena; Oscar R Burrone; Michela Cesco-Gaspere
Journal:  Front Oncol       Date:  2012-11-09       Impact factor: 6.244

7.  The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).

Authors:  Jaime R Adame-Gallegos; Jianguo Shi; Richard S McIntosh; Richard J Pleass
Journal:  Exp Parasitol       Date:  2012-02-10       Impact factor: 2.011

8.  Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region.

Authors:  Christopher M Snyder; Katja Aviszus; Ryan A Heiser; Daniel R Tonkin; Amanda M Guth; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

Review 9.  Ig Constant Region Effects on Variable Region Structure and Function.

Authors:  Alena Janda; Anthony Bowen; Neil S Greenspan; Arturo Casadevall
Journal:  Front Microbiol       Date:  2016-02-04       Impact factor: 5.640

10.  P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties.

Authors:  Darel Martínez; Nely Rodríguez; Tania Griñán; Teresa Rondón; Ana María Vázquez; Rolando Pérez; Ana María Hernández
Journal:  Front Immunol       Date:  2012-04-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.